Neurological disorders and the potential role for stem cells as a therapy

British Medical Bulletin

Volumn 101, Issue 1, 2012, Pages 163-181

  Sanberg, Paul R ^a   Eve, David J ^a   Cruz, L Eduardo ^a   Borlongan, Cesar V ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Cell therapy; Inflammation; Mesenchymal stem cells; Neural stem cells; Neurotrophic factors; Tumorigenesis

Indexed keywords

NEUROTROPHIC FACTOR;

ALLOGENEIC STEM CELL TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; CARCINOGENESIS; CARCINOGENICITY; CELL TYPE; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; NEUROLOGIC DISEASE; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION; UPREGULATION;

BIOMEDICAL RESEARCH; CELL TRANSFORMATION, NEOPLASTIC; CLINICAL TRIALS AS TOPIC; HUMANS; NERVOUS SYSTEM DISEASES; STEM CELL TRANSPLANTATION;

EID: 84858162730     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/bmb/lds001     Document Type: Review

References (73)

1. Davie CA. A review of Parkinson's disease. Br Med Bull 2008;86:109-27. (Pubitemid 351809630)
2. Rejdak K, Jackson S, Giovannoni G. Multiple sclerosis: a practical overview for clinicians. Br Med Bull 2010;95:79-104.
3. Eve DJ, Marty PJ, McDermott RJ et al. Stem cell research and health education. Am J Health Educ 2008;39:167-79.
4. Lensch MW. Cellular reprogramming and pluripotency induction. Br Med Bull 2009;90:19-35.
5. Liu SP, Fu RH, Huang YC et al. Induced pluripotent stem (iPS) cell research overview. Cell Transplant 2011;20:15-9.
6. Patel AN, Park E, Kuzman M et al. Multipotent menstrual blood stromal stem cells: isolation, characterization, and differentiation. Cell Transplant 2008;17:303-11. (Pubitemid 351717333)
7. Yu SJ, Soncini M, Kaneko Y et al. Amnion: a potent graft source for cell therapy in stroke. Cell Transplant 2009;18:111-8.
8. Karaoz E, Demircan PC, Saglam O et al. Human dental pulp stem cells demonstrate better neural and epithelial stem cell properties than bone marrow-derived mesenchymal stem cells. Histochem Cell Biol 2011;136:455-73.
9. Rodrigues MC, Voltarelli J, Sanberg PR et al. Recent progress in cell therapy for basal ganglia disorders with emphasis on menstrual blood transplantation in stroke. Neurosci Biobehav Rev 2012;36:177-90.
10. Miura M, Gronthos S, Zhao M et al. SHED: stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci USA 2003;100:5807-12. (Pubitemid 36576889)
11. Borlongan CV, Kaneko Y, Maki M et al. Menstrual blood cells display stem cell-like phenotypic markers and exert neuroprotection following transplantation in experimental stroke. Stem Cells Dev 2010;19:439-52.
12. Sanberg PR, Eve DJ, Willing AE et al. The treatment of neurodegenerative disorders using umbilical cord blood and menstrual blood-derived stem cells. Cell Transplant 2011;20:85-94.
13. Huang H, Chen L, Sanberg P. Cell therapy from bench to bedside translation in CNS neurorestoratology era. Cell Med 2010;1:15-46.
14. Santiago LY, Clavijo-Alvarez J, Brayfield C et al. Delivery of adipose-derived precursor cells for peripheral nerve repair. Cell Transplant 2009;18:145-58.
15. Vieira NM, Brandalise V, Zucconi E et al. Isolation, characterization, and differentiation potential of canine adipose-derived stem cells. Cell Transplant 2010;19:279-89.
16. Tat PA, Sumer H, Jones KL et al. The efficient generation of induced pluripotent stem (iPS) cells from adult mouse adipose tissue-derived and neural stem cells. Cell Transplant 2010;19:525-36.
17. Leung AYH, Kwong Y-L. Haematopoietic stem cell transplantation: current concepts and novel therapeutic strategies. Br Med Bull 2010;93:85-103.
18. Park DH, Eve DJ, Musso J III et al. Inflammation and stem cell migration to the injured brain in higher organisms. Stem Cells Dev 2009;18:693-702.
19. Bachstetter AD, Pabon MM, Cole MJ et al. Peripheral injection of human umbilical cord blood stimulates neurogenesis in the aged rat brain. BMC Neurosci 2008;9:22. (Pubitemid 351423981)
20. Park DH, Eve DJ, Sanberg PR et al. Increased neuronal proliferation in the dentate gyrus of aged rats following neural stem cell implantation. Stem Cells Dev 2010;19:175-80.
21. Song CH, Kim JJ, Kim JJ. Stem cell scoring system (SCSS) for selection of dominant human umbilical cord blood-derived mesenchymal stem cells (hUCB-MSCs) against senescence. Cell Transplant 2010;19:363.
22. Lau BW, Yau SY, So KF. Reproduction: a new venue for studying function of adult neurogenesis?. Cell Transplant 2011;20:21-35.
23. Yau SY, Lau BW, So KF. Adult hippocampal neurogenesis: a possible way how physical exercise counteracts stress. Cell Transplant 2011;20:99-111.
24. Brunet JF, Redmond DE Jr, Bloch J. Primate adult brain cell autotransplantation, a pilot study in asymptomatic MPTP-treated monkeys. Cell Transplant 2009;18:787-99.
25. Lévesque MF, Neuman T, Rezak M. Therapeutic microinjection of autologous adult human neural stem cells and differentiated neurons for Parkinson's disease: five-year post-operative outcome. Open Stem Cell J 2009;1:20-9.
26. Walczak P, Chen N, Eve D et al. Long-term cultured human umbilical cord neural-like cells transplanted into the striatum of NOD SCID mice. Brain Res Bull 2007;74:155-63. (Pubitemid 47187924)
27. Jackson JS, Golding JP, Chapon C et al. Homing of stem cells to sites of inflammatory brain injury after intracerebral and intravenous administration: a longitudinal imaging study. Stem Cell Res Ther 2010;1:17.
28. Yang J, Yan Y, Ciric B et al. Evaluation of bone marrow- and brain-derived neural stem cells in therapy of central nervous system autoimmunity. Am J Pathol 2010;177:1989-2001.
29. Park DH, Borlongan CV, Willing AE et al. Human umbilical cord blood cell grafts for brain ischemia. Cell Transplant 2009;18:985-98.
30. Dominici M, Le Blanc K, Mueller I et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-7. (Pubitemid 44269669)
31. Hunt DP, Irvine KA, Webber DJ et al. Effects of direct transplantation of multipotent mesenchymal stromal/stem cells into the demyelinated spinal cord. Cell Transplant 2008;17:865-73.
32. Kishk NA, Gabr H, Hamdy S et al. Case control series of intrathecal autologous bone marrow mesenchymal stem cell therapy for chronic spinal cord injury. Neurorehabil Neural Repair 2010;24:702-8.
33. Sykova E, Homola A, Mazanec R et al. Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. Cell Transplant 2006;15:675-87. (Pubitemid 46095251)
34. Joyce N, Annett G, Wirthlin L et al. Mesenchymal stem cells for the treatment of neurodegenerative disease. Regen Med 2010;5:933-46.
35. Karussis D, Karageorgiou C, Vaknin-Dembinsky A et al. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch Neurol 2010;67:1187-94.
36. Kulbatski I. Stem/precursor cell-based CNS therapy: the importance of circumventing immune suppression by transplanting autologous cells. Stem Cell Rev 2010;6:405-10.
37. Yang WZ, Zhang Y, Wu F et al. Safety evaluation of allogeneic umbilical cord blood mononuclear cell therapy for degenerative conditions. J Transl Med 2010;8:75.
38. Lee HJ, Lee JK, Lee H et al. The therapeutic potential of human umbilical cord blood-derived mesenchymal stem cells in Alzheimer's disease. Neurosci Lett 2010;481:30-5.
39. Lee JK, Jin HK, Bae JS. Bone marrow-derived mesenchymal stem cells reduce brain amyloidbeta deposition and accelerate the activation of microglia in an acutely induced Alzheimer's disease mouse model. Neurosci Lett 2009;450:136-41.
40. Nikolic WV, Hou H, Town T et al. Peripherally administered human umbilical cord blood cells reduce parenchymal and vascular beta-amyloid deposits in Alzheimer mice. Stem Cells Dev 2008;17:423-39. (Pubitemid 351948205)
41. Lee HJ, Lee JK, Lee H et al. Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer's disease mouse model through modulation of neuroinflammation. Neurobiol Aging 2012;33:588-602.
42. Blandini F, Cova L, Armentero MT et al. Transplantation of undifferentiated human mesenchymal stem cells protects against 6-hydroxydopamine neurotoxicity in the rat. Cell Transplant 2010;19:203-17.
43. Nicaise C, Mitrecic D, Pochet R. Brain and spinal cord affected by amyotrophic lateral sclerosis induce differential growth factors expression in rat mesenchymal and neural stem cells. Neuropathol Appl Neurobiol 2011;37:179-88.
44. Borlongan CV, Hadman M, Sanberg CD et al. Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke 2004;35:2385-9. (Pubitemid 39311268)
45. Jiang Y, Zhu J, Xu G et al. Intranasal delivery of stem cells to the brain. Expert Opin Drug Deliv 2011;8:623-32.
46. Yasuhara T, Hara K, Maki M et al. Intravenous grafts recapitulate the neurorestoration afforded by intracerebrally delivered multipotent adult progenitor cells in neonatal hypoxic-ischemic rats. J Cereb Blood Flow Metab 2008;28:1804-10.
47. Jozwiak S, Habich A, Kotulska K et al. Intracerebroventricular transplantation of cord bloodderived neural progenitors in a child with severe global brain ischemic injury. Cell Med 2010;1:71-80.
48. van Velthoven CT, Kavelaars A, van Bel F et al. Repeated mesenchymal stem cell treatment after neonatal hypoxia-ischemia has distinct effects on formation and maturation of new neurons and oligodendrocytes leading to restoration of damage, corticospinal motor tract activity, and sensorimotor function. J Neurosci 2010;30:9603-11.
49. Delcroix GJ, Schiller PC, Benoit JP et al. Adult cell therapy for brain neuronal damages and the role of tissue engineering. Biomaterials 2010;31:2105-20.
50. Matsuda R, Yoshikawa M, Kimura H et al. Cotransplantation of mouse embryonic stem cells and bone marrow stromal cells following spinal cord injury suppresses tumor development. Cell Transplant 2009;18:39-54.
51. Oh JS, Kim KN, An SS et al. Cotransplantation of mouse neural stem cells (mNSCs) with adipose tissue-derived mesenchymal stem cells improves mnsc survival in a rat spinal cord injury model. Cell Transplant 2011;20:837-49.
52. Ellis-Behnke RG, Liang YX, Guo J et al. Forever young: how to control the elongation, differentiation, and proliferation of cells using nanotechnology. Cell Transplant 2009;18:1047-58.
53. Bozkurt G, Mothe AJ, Zahir T et al. Chitosan channels containing spinal cord-derived stem/ progenitor cells for repair of subacute spinal cord injury in the rat. Neurosurgery 2010;67:1733-44.
54. Borlongan CV, Thanos CG, Skinner SJ et al. Transplants of encapsulated rat choroid plexus cells exert neuroprotection in a rodent model of Huntington's disease. Cell Transplant 2008;16:987-92. (Pubitemid 351732840)
55. Qu C, Mahmood A, Liu XS et al. The treatment of TBI with human marrow stromal cells impregnated into collagen scaffold: functional outcome and gene expression profile. Brain Res 2011;1371:129-39.
56. Amariglio N, Hirshberg A, Scheithauer BW et al. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med 2009;6:e1000029.
57. Amariglio N, Rechavi G. On the origin of glioneural neoplasms after neural cell transplantation. Nat Med 2010;16:157; author reply 157-8.
58. Tsuji O, Miura K, Okada Y et al. Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc Natl Acad Sci USA 2010;107:12704-9.
59. Park HJ, Kim JK, Jeon HM et al. The neural stem cell fate determinant TLX promotes tumorigenesis and genesis of cells resembling glioma stem cells. Mol Cells 2010;30:403-8.
60. Joseph NM, Mosher JT, Buchstaller J et al. The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells. Cancer Cell 2008;13:129-40. (Pubitemid 351163162)
61. Spaeth EL, Dembinski JL, Sasser AK et al. Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One 2009;4:e4992.
62. Mack GS. ReNeuron and stemcells get green light for neural stem cell trials. Nature Biotechnology 2011;29:95-7.
63. Volarevic V, Ljujic B, Stojkovic P et al. Human stem cell research and regenerative medicine - present and future. Br Med Bull 2011;99:155-68.
64. Gaspard N, Bouschet T, Herpoel A et al. Generation of cortical neurons from mouse embryonic stem cells. Nat Protoc 2009;4:1454-63.
65. Eiraku M, Watanabe K, Matsuo-Takasaki M et al. Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals. Cell Stem Cell 2008;3:519-32.
66. Liu Y, Zhang SC. Human stem cells as a model of motoneuron development and diseases. Ann N Y Acad Sci 2010;1198:192-200.
67. Zhao T, Zhang ZN, Rong Z et al. Immunogenicity of induced pluripotent stem cells. Nature 2011;474:212-5.
68. Pera MF. Stem cells: the dark side of induced pluripotency. Nature 2011;471:46-7.
69. Van Dycke A, Raedt R, Verstraete A et al. Astrocytes derived from fetal neural progenitor cells as a novel source for therapeutic adenosine delivery. Seizure 2010;19:390-6.
70. Robinson AJ, Zhao G, Rathjen J et al. Embryonic stem cell-derived glial precursors as a vehicle for sulfamidase production in the MPS-IIIA mouse brain. Cell Transplant 2010;19:985-98.
71. Moloney TC, Rooney GE, Barry FP et al. Potential of rat bone marrow-derived mesenchymal stem cells as vehicles for delivery of neurotrophins to the Parkinsonian rat brain. Brain Res 2010;1359:33-43.
72. Glavaski-Joksimovic A, Virag T, Mangatu TA et al. Glial cell line-derived neurotrophic factor-secreting genetically modified human bone marrow-derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease. J Neurosci Res 2010;88:2669-81.
73. Gaspar HB, Cooray S, Gilmour KC et al. Hematopoietic stem cell gene therapy for adenosine deaminase-deficient severe combined immunodeficiency leads to long-term immunological recovery and metabolic correction. Sci Transl Med 2011;3:97ra80.